Speaker illustration

Doctor Teona Shvangiradze

Endocrinology Research Center, Moscow (Russian Federation)

Transforming growth factor beta and fibroblast growth factor 21 in cardiovascular prognosis in patients with obesity and type 2 diabetes mellitus

Event: ESC CONGRESS 2017

Topic: Diabetes, dysglycaemia and metabolic syndrome

Session: Diabetes

Thumbnail

Cardiovascular-related microRNAs in patients with obesity and type 2 diabetes mellitus

Event: ESC CONGRESS 2017

Topic: Diabetes, dysglycaemia and metabolic syndrome

Session: Diabetes

Thumbnail

This platform is supported by

logo Novo Nordisk